{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1fYJtKpg2Z\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/13003\/\">2003 \u5e74 1 \u6708 24 \u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/13003\/embed\/#?secret=1fYJtKpg2Z\" width=\"600\" height=\"338\" title=\"\u201c\u300c2003\u5e741\u670824\u65e5\u7248 \u52d5\u7269\u533b\u7642\u30cb\u30e5\u30fc\u30b9\uff06\u60c5\u5831\u300d \u2014 \u30d6\u30e9\u30c3\u30b1\u30fb\u30b3\u30f3\u30b5\u30eb\u30c6\u30a3\u30f3\u30b0\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\" data-secret=\"1fYJtKpg2Z\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"****************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for January 24, 2003 Copyright &copy; Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES &gt;&nbsp; Pfizer announced that Animal Health sales in the fourth quarter of 2002 increased 8% to $325 million, compared to the same period in 2001. This performance was led by the strong growth of companion-animal products Revolution, Clavamox, and Synulox; and livestock medicine RespiSure\/Stellamune. Full-year Animal Health sales increased 10% to $1.119 billion. (company website) &gt;&nbsp; Eli Lilly announced that worldwide sales of its animal health subsidiary Elanco in the fourth quarter of 2002 were $195.5 million, an increase of 4% compared with the fourth quarter of 2001. For the full year of 2002, animal health sales increased 1%, to $693.1 million. Excluding the effect of exchange rates, sales increased by 6% for the quarter and 3% for the year.&nbsp; (Business Wire) &gt;&nbsp; Schering-Plough reported fourth quarter 2002 sales of its animal health division were $193 million, a decrease of 4% over the fourth quarter of 2001.&nbsp; Sales for the full year decreased 2% to $677 million.&nbsp; (company website) &gt;&nbsp; Novartis announced results for the year 2002.&nbsp; In Animal Health, sales were up 10% in local currencies (1% in CHF) to CHF 970 million ($626 million), driven by double-digit growth in the LATAM region and the US, where theView Full Post;"}